{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "3555174",
  "DateCompleted": {
    "Year": "1987",
    "Month": "06",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0196-6553",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "2",
        "PubDate": {
          "Year": "1987",
          "Month": "Apr"
        }
      },
      "Title": "American journal of infection control",
      "ISOAbbreviation": "Am J Infect Control"
    },
    "ArticleTitle": "Staphylococcus epidermidis: a significant nosocomial pathogen.",
    "Pagination": {
      "StartPage": "59",
      "EndPage": "74",
      "MedlinePgn": "59-74"
    },
    "Abstract": {
      "AbstractText": [
        "Staphylococcus epidermidis is an organism formerly believed to be nonpathogenic. It is now recognized as a pathogen, causing infections on implanted devices and among immunosuppressed patients. Further, it has been involved in the development of resistance to a number of antibiotics. The epidemiology of this organism, its pathogenesis, and its treatment are important to infection control practitioners."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hamory",
        "ForeName": "B H",
        "Initials": "BH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Parisi",
        "ForeName": "J T",
        "Initials": "JT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hutton",
        "ForeName": "J P",
        "Initials": "JP"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am J Infect Control",
    "NlmUniqueID": "8004854",
    "ISSNLinking": "0196-6553"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Am J Infect Control 1987 Aug;15(4):158"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Bacteriophage Typing"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Catheterization"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Cerebrospinal Fluid Shunts"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "etiology"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [
        "etiology"
      ],
      "DescriptorName": "Endocarditis, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Peritoneal Dialysis, Continuous Ambulatory"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Plasmids"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Premedication"
    },
    {
      "QualifierName": [
        "etiology"
      ],
      "DescriptorName": "Sepsis"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "etiology"
      ],
      "DescriptorName": "Staphylococcal Infections"
    },
    {
      "QualifierName": [
        "classification",
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "Staphylococcus epidermidis"
    }
  ],
  "NumberOfReferences": "125"
}